Page 2 - Les meilleurs doctors traitant la maladie suivante : Basaliome - TOP -51 des médecins

Le Dr Yildiz a publié plus de 15 articles évalués par des pairs sur un large éventail de cancers dans des revues internationales de renom.

• Plus de 10 ans d'expérience en oncologie médicale.
• Co-auteur de l'étude MODEST sur la gestion du diabète chez les patients suivant des traitements oncologiques.
• Expertise incluant les tumeurs neuroendocrines et les syndromes paranéoplasiques.
• Publications sur des cas complexes tels que le thymome et le neuroblastome.
• Travail à l'hôpital universitaire Medipol Mega à Istanbul.

Le Dr Christiane Thallinger est spécialisée dans le cancer de la peau, se concentrant sur le carcinome basocellulaire avec plus de deux décennies d'expertise à la Wiener Privatklinik.

• Dermatologue certifiée avec une formation approfondie en dermoscopie et en excision de tumeurs cutanées
• Experte dans la gestion des effets secondaires dermatologiques des thérapies anticancéreuses
• Affiliée à l'Université de médecine de Vienne pour la recherche
• Utiliser des techniques avancées comme la thérapie photodynamique pour un traitement précis

Le Dr Ozatli se spécialise dans les cancers du sein, du poumon et gastro-intestinaux, avec une vaste expérience en oncologie dans plusieurs hôpitaux turcs.

• Professeur agrégé depuis 2016
• Travailler à la clinique d'oncologie d'Ankara et à l'hôpital régional de formation et de recherche d'Erzurum
• Étudier la médecine à l'université de Selcuk

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Le Dr Alemdar est spécialisé en oncologie médicale, ayant suivi une formation approfondie à l'Université Akdeniz, une institution de premier plan en Turquie.

• Certifié en oncologie médicale depuis 2018
• Plus de 15 ans d'expérience en médecine interne et en oncologie
• A travaillé dans plusieurs hôpitaux prestigieux, dont l'hôpital universitaire d'Akdeniz

Le professeur Paksoy est spécialisé en oncologie médicale, avec un accent particulier sur le basaliome, exerçant ses fonctions à l’hôpital Medipol Bahçelievler.

• Suivre une formation de spécialisation en oncologie médicale à l’Institut d’oncologie de l’université d’Istanbul
• Être certifié par l’ESMO en oncologie médicale depuis 2022
• Participer activement à de multiples essais cliniques internationaux pour divers types de cancers
• Publier de nombreux articles de recherche en oncologie, notamment sur les cancers de la peau

Spécialisée en virothérapie – l'un des domaines les plus récents de l'immunologie – le Dr Jaunalksne apporte des approches de traitement de pointe.

• Plus de 30 ans d'expérience en immunologie
• Chef du centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins
• Diplômée de l'Institut de médecine de Riga avec un internat en médecine interne

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Spécialisé dans le traitement du cancer de la peau avec une formation spécialisée au St John’s Institute of Dermatology à Londres – un leader mondial en oncologie cutanée.

• Chercheur principal en cancer de la peau aux hôpitaux Guy’s and St Thomas’
• Conférencier sur le cancer de la peau non mélanome au King’s College de Londres
• Membre de l'Académie Européenne de Dermatologie et de Vénérologie
• Formé aux techniques de chirurgie dermatologique à Tel-Aviv et à Londres

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Le Dr Bergman est un dermatologue spécialisé en oncodermatologie, se concentrant sur le diagnostic et le traitement des cancers de la peau tels que le basaliome.

• Travailler au centre médical Rambam, un hôpital israélien majeur
• Double expertise en tant que dermatologue et oncodermatologue
• Se spécialiser dans le cancer de la peau, ce qui le rend très pertinent pour les cas de basaliome

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Spécialisé en oncologie radiothérapique à l'Université de Marmara – se concentre sur les traitements de précision contre le cancer.

• Certifié en oncologie radiothérapique avec des années de formation spécialisée
• Diplômé du programme de médecine en anglais de l'Université de Marmara
• Travaille au centre de traitement du cancer de l'Hôpital Emsey